FACULTY
|
A/PROF GRACE KONG
Nuclear Medicine Physician Department of Oncology Peter MacCallum Cancer Centre (PMCC) Melbourne, Australia Grace Kong is a Nuclear Medicine Physician at the Peter MacCallum Cancer Centre (PMCC) in Melbourne Australia, a Clinical Associate Professor at the University of Melbourne, Sir Peter MacCallum Department of Oncology. She is the Co-Chair of the Neuroendocrine Tumour (NET) Unit, a European Neuroendocrine Tumor Society (ENETS) Center of Excellence. She has clinical leadership roles as the Lead of Radionuclide Therapy at PMCC, Chair of the NET multidisciplinary meeting (MDM), and the Nuclear Medicine Lead for the upper gastrointestinal tumour MDM. She was a recipient of the Foundation Discovery Partner Fellowship grant award.
Grace graduated from Monash University (Australia) and previously completed a fellowship in PET and radionuclide therapy at the Royal Marsden Hospital in UK. She has broad clinical and research interests in using molecular imaging to characterize cancer, with a focus on advancing theranostics, radionuclide therapy and precision medicine for treating NET, endocrine, prostate and other cancers. She has published multiple practice-changing peer-reviewed articles, particularly in NET and peptide receptor radionuclide therapy (PRRT). She is the CPI / PI for 10+ active prospective national and international collaborative diagnostic and theranostics trials and is a co-investigator of many oncologic studies, particularly in NET, prostate cancer and thyroid cancer. She actively participates in research and education at national and international meetings, is a member of the AANMS committee for Theranostics education. She is engaged in patient education and advocacy as a committee member of Neuroendocrine Cancer Australia. Her vision is to be a lead clinician-researcher, to improve patient outcomes through collaborative prospective clinical and translational research. |
